During the past year, there was a frenzy to acquire drug assets aimed at the hepatitis C virus (HCV).

FORBES: Big Pharma Failures Light the Way to Change

Chronic infection with hepatitis C virus (HCV) is estimated to affect 170 million people worldwide, and more than five million in Europe.

BBC: Better treatment for Hepatitis C

The investigators recruited 832 patients aged 18 years or more with chronic HCV who had not been treated with interferon or ribavirin.

BBC: Better treatment for Hepatitis C

Writing in the Lancet medical journal, researchers from The International Hepatitis Interventional Therapy Group report a new treatment for chronic HCV infection that uses a combination of interferon alpha-2b and a drug called ribavirin.

BBC: Better treatment for Hepatitis C